Archive Posts

Archive

Govzilla’s Top 20 Posts of All Time

Amy Filbin
Archive

March 483s: Most Popular and Newsworthy

Barbara W. Unger
Archive

Warning Letters Week of 3/15/2020: Data Governance Failures

Barbara W. Unger
Archive

February 483s: Most Popular and Newsworthy

Barbara W. Unger
Archive

January 483s: Most Popular and Newsworthy

Barbara W. Unger
Archive

November 483s: Most Popular and Newsworthy

Barbara W. Unger
Archive

October 483s: Most Popular and Newsworthy

Barbara W. Unger
Archive

Week of October 20th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

FY2018 FDA Drug Inspection Observations And Trends

Barbara W. Unger
Archive

Week of October 13th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of October 6th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Repeat Deficiencies in Lupin Limited Warning Letters

Barbara W. Unger
Archive

Week of September 29th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

September 483s: Most Popular and Newsworthy

Jessica Strmiska
Archive

FDAzilla’s Top 20 Posts of All Time

Jessica Strmiska
Archive

Week of September 15th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of September 8th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Introducing Jonathan Rochez, Redica Systems’s New VP of Engineering

Amy Filbin
Archive

Week of August 25th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Gaining GMP Expertise: Govzilla Adds Jane Wastl as Senior GMP Quality Expert

Amy Filbin
Archive

Govzilla Adds Jerry Chapman as Senior GMP Quality Expert

Amy Filbin
Archive

Upcoming Webinar: It’s Not All on the Web – Finding the FDA Information You Didn’t Know You Could Have

Amy Filbin
Archive

Week of August 18th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Review of the Office of Compliance CY2018 Annual Report

Barbara W. Unger
Archive

Week of August 11th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of August 4th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of July 28th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of July 21st, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

June 2019 | New FDA 483s

Jessica Strmiska
Archive

Week of July 14th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Warning Letters Week of July 7, 2019: Poor Aseptic Practices

Barbara W. Unger
Archive

Week of June 30th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of June 23rd, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Govzilla Speaking at KENX’s GMP University

Amy Filbin
Archive

Week of June 17th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

We’re Hiring! Account Manager Needed

Amy Filbin
Archive

May 2019 | New FDA 483s

Jessica Strmiska
Archive

Week of June 10th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of June 3rd, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

April 2019 | New FDA 483s

Jessica Strmiska
Archive

Week of May 26th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of May 19th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of May 13th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

Week of May 5th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

March 2019 | New FDA 483s

Jessica Strmiska
Archive

Week of April 28th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Barbara W. Unger
Archive

February 2019 | New FDA 483s

Jessica Strmiska
Archive

January 2019 | New FDA 483s

Jessica Strmiska